Evidence map›Paper›PMID 31318902›Full record

Trial reportPloS one2019

A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: A pilot study.

Fabian Frost, Lena J Storck, Tim Kacprowski, Simone Gärtner, Malte Rühlemann, Corinna Bang, Andre Franke, Uwe Völker, Ali A Aghdassi, Antje Steveling and 4 more

2 registry-linked trialsOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 6 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02970838 nacompletednot on this map

Evaluation of a Structured Weight-loss Program for Therapy of Obesity and Diabetes Mellitus Type 2

TypeinterventionalSponsorUniversity Medicine GreifswaldRan2012 to 2014Enrolled36ConditionsObesity, Diabetes Type 2, Weight LossArmsStructured weight-loss program
NCT04207879 unknown statusnot on this mapstarted 2020, after this paper: background citation

Longitudinal Profiling of Gut Microbiome in Overweight or Obese Participants on a Modified Atkins Diet: a Prospective Cohort Study

TypeobservationalSponsorHebei Medical University Third HospitalRan2020 to 2023Enrolled75ConditionsOverweight or Obesity
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 6 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Biomedicines · 2026
    Article
  16. Article
  17. Diet, gut microbiota, and health: a review.Food science and biotechnology · 2025
    Review
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Fabian FrostDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-1502-8888
Lena J StorckDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Tim KacprowskiDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Simone GärtnerDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Malte RühlemannInstitute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.ORCID 0000-0002-0685-0052
Corinna BangInstitute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.ORCID 0000-0003-1530-5811
Uwe VölkerDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Ali A AghdassiDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Antje StevelingDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Julia MayerleDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Frank U WeissDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Georg HomuthDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Markus M LerchDepartment of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Universitätsmedizin Greifswald · DEChristian-Albrechts-Universität zu Kiel · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global obesity epidemic constitutes a major cause of morbidity and mortality challenging public health care systems worldwide. Thus, a better understanding of its pathophysiology and the development of novel therapeutic options are urgently needed. Recently, alterations of the intestinal microbiome in the obese have been discussed as a promoting factor in the pathophysiology of obesity and as a contributing factor to related diseases such as type 2 diabetes and metabolic syndrome. The present pilot study investigated the effect of a structured weight loss program on fecal microbiota in obese type 2 diabetics. Twelve study subjects received a low-calorie formula diet for six weeks, followed by a nine week food reintroduction and stabilization period. Fecal microbiota were determined by 16S rRNA gene sequencing of stool samples at baseline, after six weeks and at the end of the study after fifteen weeks. All study subjects lost weight continuously throughout the program. Changes in fecal microbiota were most pronounced after six weeks of low-calorie formula diet, but reverted partially until the end of the study. However, the gut microbiota phylogenetic diversity increased persistently. The abundance of Collinsella, which has previously been associated with atherosclerosis, decreased significantly during the weight loss program. This study underlines the impact of dietary changes on the intestinal microbiome and further demonstrates the beneficial effects of weight loss on gut microbiota. Trial registration: ClinicalTrials.gov NCT02970838.

Indexed as

Gastrointestinal MicrobiomePhylogenyActinobacteriaBiodiversityBody Mass IndexDiabetes Mellitus, Type 2FecesFemaleHumansMaleMiddle AgedObesityPrincipal Component AnalysisWeight Reduction Programs

Identifiers

PMID31318902
PMCPMC6638920
OpenAlexW2963327097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.